Radiotherapy for Newly Diagnosed Glioblastoma in the Elderly: What Is the Standard?

Nearly half of the patients with newly diagnosed glioblastomas are aged ≥65 years. Unfortunately, these elderly patients with glioblastoma (GBM-e) demonstrate detrimental survival. However, the optimal treatment for GBM-e after surgery remains controversial. Conventionally fractionated radiotherapy...

Descripción completa

Detalles Bibliográficos
Autor principal: Wee, Chan Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819463/
https://www.ncbi.nlm.nih.gov/pubmed/35118843
http://dx.doi.org/10.14791/btrt.2022.10.e34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819463/
https://www.ncbi.nlm.nih.gov/pubmed/35118843
http://dx.doi.org/10.14791/btrt.2022.10.e34

Ejemplares similares